Brief: SeQuent Scientific Gets EIR From US FDA For Bengaluru Analytical Laboratory
20/08/2019 08:01
Aug 20 (Reuters) - SeQuent Scientific Ltd SEQU.NS :
* GETS EIR FROM US FDA FOR ITS ANALYTICAL LABORATORY AT
BENGALURU
Source text: http://bit.ly/30lmdfQ
Further company coverage: SEQU.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viyash Scientific
See all newsBrief: Viyash Scientific Says Bioforlife Italia Acquisition Expected To Complete Within Two Months From Sept 8
Brief: Viyash Scientific Ltd June-Quarter Consol Net Profit 658.7 Million Rupees
Brief: Viyash Scientific's Subsidiary To Buy 100% Of Bioforlife Italia
Brief: Viyash Scientific March-Quarter Consol Net Profit 521.1 Million Rupees
Brief: Viyash Scientific Partners With Boehringer Ingelheim In India